Compounds and medicinal use thereof

Details Compounds and medicinal use thereof Compounds and medicinal use thereof

2008-01-01

2008-01-01

O'Sullivan, Peter (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S538000, C514S539000, C514S544000, C514S545000, C514S567000, C514S568000, C514S570000, C514S571000, C560S009000, C560S019000, C560S020000, C560S021000, C560S052000, C560S101000, C562S426000, C562S435000, C562S441000, C562S560000

Reexamination Certificate

active

07314888

ABSTRACT:
A compound or a salt thereof having the atom corresponding to N3and the two or more atoms selected from N1, N2, N4and N5, said atoms constitute the pharmacophore represented by the following formula:and inhibits the activity of transcription factor AP-1 and is useful as an agent for preventing and treating the diseases into which over expression of AP-1 participates and as an AP-1 inhibitor.

REFERENCES:
patent: 3478087 (1969-11-01), McGrath et al.
patent: 4389416 (1983-06-01), Plattner
patent: 5235064 (1993-08-01), Gapinski
patent: 5434186 (1995-07-01), Cohen et al.
patent: 5852046 (1998-12-01), Lang et al.
patent: 1 138 792 (1962-10-01), None
patent: 2 064 304 (1972-07-01), None
patent: 0 150 166 (1985-07-01), None
patent: 0 276 064 (1988-01-01), None
patent: 639 572 (1991-07-01), None
patent: 0 531 823 (1992-08-01), None
patent: 639 573 (1995-02-01), None
patent: 0 856 582 (1998-08-01), None
patent: 7-145149 (1995-06-01), None
patent: 10-36272 (1998-02-01), None
patent: 10-130201 (1998-05-01), None
patent: WO 96/40189 (1996-12-01), None
J. N. M. Glover, et al.,Letters To Nature, vol. 373, No. 6511, pp. 257-261, “Crystal Structure of the Heterodimeric bZIP Transcription Factor c-Fos-c-JUN Bound to DNA,” Jan. 19, 1995.
Y. Nishibata, et al., Tetrahedron, vol. 47, No. 43, pp. 8985-8990, “Automatic Creation of Drug Candidate Structures Based on Receptor Structure. Starting Point for Artificial Lead Generation,” 1991.
Y. C. Martin, et al., Journal Of Medicinal Chemistry, vol. 35, No. 12, pp. 2145-2154, “3D Database Searching in Drug Design,” Jun. 12, 1992.
S. Yao, et al., Biopolymers, vol. 47, No. 4, pp. 277-283, “Uncoiling c-JUN Coiled Coils: Inhibitory Effects of Truncated FOS Peptides on JUN Dimerization and DNA Binding In Vitro,” 1998.
M. Cushman, et al., Journal of Medicinal Chemistry, vol. 41, No. 12, pp. 2076-2089, “New Alkenyldiarylmethanes With Enhanced Potencies as Anti-HIV Agents Which Act as Non-Nucleoside Reverse Transcriptase Inhibitors,” 1998.
N. Neamati, et al., Journal of Medicinal Chemistry, vol. 40, No. 6, pp. 942-951, “Depsides and Depsidones as Ingibitors of HIV-1 Integrase: Discovery of Novel Inhibitors Through 3D Database Searching,” 1997.
M. Cushman, et al., Biochemical and Biophysical Research Communications, vol. 185, No. 1, pp. 85-90, “Inhibition of HIV-1 Integration Protein by Aurintricarboxylic Acid Monomers, Monomer Analogs, and Polymer Fractions,” May 29, 1992.
Andrea Fanjui, et al., “A New Class of Retinoids With Selective Inhibition of AP-1 Inhibits Proliferation,” Letter to Nature, XP-000579772, vol. 372, No. 6501, Nov. 3, 1994, pp. 107-111.
Robert W. Sullivan, et al., “2-Chloro-4-(Trifluoromethyl)Pyrimidine-5-N-(3′,5′-Bis(Trifluoromethyl)Phenyl)-Carboxamide: A Potent Inhibitor of NF-Kb- and AP-1-Mediated Gene Expression Identified Using Solution-Phase Combinatorial Chemistry,” Journal of Medicinal Chemistry, American Chemical Society, XP-002328712, vol. 41, No. 4, Jan. 24, 1998, pp. 413-419.
M. E. Goldman, et al., “SP100030 is a Novel T-Cell-Specific Transcription Factor Inhibitor That Possesses Immunosuppressive Activity In Vivo,” Transplantation Proceedings, XP-001095817, vol. 28, No. 6, Dec. 1996, pp. 3106-3109.
Masaki Goto, et al., “K1115 A, A New Anthraquinone Derivative That Inhibits the Binding of Activator Protein-1 (AP-1) to Its Recognition Sites,” The Journal of Antibiotics, XP-008066756, vol. 51, No. 6, Jun. 1998, pp. 539-544.
Keiichi Tsuchida, et al., “Design, Synthesis and Biological Evaluation of New Cyclic Disulfide Decapeptides That Inhibit the Binding of AP-1 to DNA,” Journal of Medicinal Chemistry, XP-002390592, vol. 47, No. 17, Aug. 12, 2004, pp. 4239-4246.
Kossoy, A.D., et al. : “Novel Computational Method for the Determination of Partition Coefficients by Planar Chromatography” Anal. Chem, vol. 64, No. 13, 1992, pp. 1345-1349, XP-002421882.
Gapinski, D.M., et al., “Benzophenone Dicarboxylic Acid Antagonists of Leukotriene B4. 1. Structure-Activity Relationships of the Benzophenone Nucleus” J. Med. Chem, vol. 33, No. 1990, pp. 2798-2807, XP00241883.
Bhavsar, M.D., et al.: “Synthesis Of Hydroxy-Aryl Ketones as UV Absorbers-IV”, Man-Made Textiles in India, vol. 31, No. 12, 1988, pp. 529-535, 556, XP009079332.
Van Der Zanden, J.M., et al.: Polymerization of ortho-methoxy-allybenzene. Dimerization combined with hydration Recueil des Travaux Chimiques des Pays-Bas et de la Belgique, vol. 74, 1955, pp. 876-888, XP009079324.
Reichel, I., et al. “Neue Erkenntnisse zur Synthese aromatischer Ketonsäuren und Beiträge zur Kenntnis der molekularen Additionsverbindung (A1C13×CH3N02)” Rev. Chim. Acad. Rep. Populaire Roumaine, vol. 5, No. 1, 1960, pp. 67-84, XP009079368.
Mitter, P.C. et al.: “Friedel and Crafts Reaction with Phenolic Acids”, J. Indian Chem. Soc.,, vol. 9, 1932, pp. 247-250, XP009079322.
Heller, G. , et al.: “Über die o-[p'-Brom-m' -toluyl]-benzoesäaure” Berichte der Deutschen Chemischen Gesellschaft [Abteilung]B: Abhandlungen, vol. 50B, 1925, pp. 497-499, XP009079321.
Carpenter, A.T., et al.: “Phenol-formaldehyde and allied resins. III. Further synthesis of resole molecules”, J. Appl. Chem., vol. 3, 1953, pp. 486-495, XP009079323.
Dutta, P.L., et al.: “Synthesis and biological activity of a series of aspartate transcarbarnoylase inhibitors: N-substituted diethyl aspartates and N-substituted-3-oxo-1, 4-piperazine-2-acetic c acid esters” J. Pharm., Sciences, vol. 79, No. 5, 1990, XP009078747.
Quellet, R., et al., No. 303. Chlorométhylation de l'acide salicylique et des éthers phénoliques correspondants. Préparation de phénols (et ethers phénoliques) amido aminés en position 1-2-4, Préparation de dérivés du diphényl méthane et de la benzophénone et bis-benzophénones Bulletin de la Societe Chimique de France, vol. 5, 1969. pp. 1698-1705, XP009078837.
Kuhlmann, R., et al.: “Transient photocurrents induced by laser flash phototysis of aromatic carbonyl compounds in solution” J. Photochem,. vol. 7, 1977, pp. 287-296, XP002421893.
Philip, J,. et al,: “The synthesis of disalicyl alcohols”, J. Med. Chem., vol. 8, No. 3, 1965, p. 405, XP002421894.
Prajapati, S.P.. et al.; “Studies on 4, 4′-dihydroxydiphenyl methane” J. Indian Chem. Soc., vol. 49, 1972, pp. 391-396, XP009079553.
Sapunov, V. I. , et al., “Order of formulation of Intermediate acids during liquid-phase oxidation of tetramethylbenzophenone” J. Org. Chem. USSR (Engl. Transl.), vol. 9, 1973, pp. 2386-2388, XP009079542.
Calvet, F. et al,: “119. The condensation of chloral with salicylic acid” J. Chem. Soc., 1936, pp. 554-556, XP009079555.
Dong, Z., et al.: “Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins”, Cancer Research, vol. 57, 1997I, pp. 4414-4419, XP-002421895.
Chung, J.Y., et al.,: Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: Structure-activity relationship and mechanisms involved Cancer Research, vol. 59, Sep. 15, 1999, pp. 4610-4617, XP002421896.
Tsuchida, K., et al.::“Discovery of non-peptidic small-molecule AP-1 inhibitors: Lead hopping based on a three-dimensional pharmacophore model” J. Med Chem., vol. 49, No. 1, Jan. 12, 2005, pp. 80-91, XP002421897.

Affiliated with

Also associated with

Rating

Compounds and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and medicinal use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2797674